APA (7th ed.) Citation

Lam, C. S. P., Rodriguez, A., Aminian, A., Ferrannini, E., Heerspink, H. J. L., Jastreboff, A. M., . . . Nissen, S. E. (2025). Tirzepatide for reduction of morbidity and mortality in adults with obesity: Rationale and design of the SURMOUNT‐MMO trial. Obesity (19307381), 33(9), 1645. https://doi.org/10.1002/oby.24332

Chicago Style (17th ed.) Citation

Lam, Carolyn S. P., et al. "Tirzepatide for Reduction of Morbidity and Mortality in Adults with Obesity: Rationale and Design of the SURMOUNT‐MMO Trial." Obesity (19307381) 33, no. 9 (2025): 1645. https://doi.org/10.1002/oby.24332.

MLA (9th ed.) Citation

Lam, Carolyn S. P., et al. "Tirzepatide for Reduction of Morbidity and Mortality in Adults with Obesity: Rationale and Design of the SURMOUNT‐MMO Trial." Obesity (19307381), vol. 33, no. 9, 2025, p. 1645, https://doi.org/10.1002/oby.24332.